Spherical Equivalent Refraction versus Axial Length for Monitoring Childhood Myopia and Estimating Disease Risk: A Systematic Review and Meta-Analysis
Listen to this summary
The authors aimed to evaluate whether spherical equivalent refraction (SER) or axial length (AL) is a more effective measure for monitoring childhood myopia progression and predicting related adult pathologies. Their systematic review and meta-analysis of 70 studies revealed that while AL thresholds identify a small group at high retinal risk, SER provides a more comprehensive assessment of cataract and primary open-angle glaucoma risks across the broader myopic population. Consequently, they recommend using SER as the primary metric for monitoring childhood myopia, with AL reserved for cases of significant axial elongation.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from American journal of ophthalmology
View all →Mar 25, 2026 · American journal of ophthalmology
Hyperreflective foci contiguous with the RPE associate with visual function in aging, early and intermediate AMD: MACUSTAR study report
Mar 25, 2026 · American journal of ophthalmology
Forecasting the Workforce of Uveitis Specialists
Mar 23, 2026 · American journal of ophthalmology
Short-Term Axial Length Changes Predict Progression of Myopic Maculopathy in Pediatric High Myopia
Mar 22, 2026 · American journal of ophthalmology
Quantifying Orbital Segmentation in Thyroid Eye Disease- Fat to Muscle Ratio correlates with Restrictive Strabismus
Mar 20, 2026 · American journal of ophthalmology
Imaging Measures for the Assessment of Disease Activity in Non-Infectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Taskforce: Report 10
Mar 20, 2026 · American journal of ophthalmology
NON-INFECTIOUS POSTERIOR UVEITIDES - Atypicals, Variants, and Masquerades: the jungle of differential diagnosis
More in Ophthalmology
View all →Mar 25, 2026 · The New England journal of medicine
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
Mar 24, 2026 · Lancet (London, England)
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial
Mar 24, 2026 · Journal of cataract and refractive surgery
Evaluation of spectacle independence with the Dutch Patient-Reported Spectacle Independence Questionnaire
Mar 24, 2026 · Journal of cataract and refractive surgery
Role of toric intraocular lenses in the correction of keratoconic eyes with cataract
Mar 23, 2026 · The New England journal of medicine
The Inherited Basis of Coronary Artery Disease
Mar 23, 2026 · Lancet (London, England)
Primary sclerosing cholangitis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


